Thank you for your interest in contracting with Cognition Therapeutics for grant funded opportunities. To be considered, please complete the Preferred Vendor Application PDF and email it to sourcing@cogrx.com. If your company is a potential good fit, we will reach out you with information about future opportunities for which you may submit a bid.
Current needs:
Cognition Therapeutics is currently conducting a Phase 2 trials in Alzheimer’s disease (START), and geographic atrophy secondary to dry age-related macular degeneration (MAGNIFY). Vendors with experience in neurological and neuro-ophthalmic diseases concentrating in the clinical / non-clinical spaces should submit their information. Accepted vendors will be given opportunities to bid on services as needed on a rolling basis. The following immediate needs exist.
All forms of patient recruitment and/or retention options including, but not limited to:
- Digital and social media campaigns;
- AI applications;
- ePro
Cognition Therapeutics has been awarded a grant from NIH for the START clinical trial. Qualified vendors will be considered for other federally funded opportunities as they become available. Information regarding our clinical trials can be found at www.cogrx.com/clinical-trials or www.clinicaltrials.gov. Cognition Therapeutics recognizes the importance and value brought by small and minority businesses, veteran-owned businesses, and women’s business enterprises to contracting opportunities. We actively encourage their participation.
If you have any questions or concerns about contracting opportunities, please contact sourcing@cogrx.com.
If you have any questions or concerns about contracting opportunities, please contact us at sourcing@cogrx.com.
Last Updated: February 2024